CPC
REGN icon

Cookson Peirce & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Cookson Peirce & Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-987
Closed -$553K – 179
2020
Q3 		$553K Buy
987
+115
+13% +$69.7K 0.04% 106
2020
Q2 		$544K Sell
872
-2
-0.2% -$1.14K 0.05% 103
2020
Q1 		$427K Buy
+874
New +$361K 0.05% 103
2015
Q3 		– Sell
-420
Closed -$214K – 152
2015
Q2 		$214K Buy
+420
New +$205K 0.04% 119

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cookson Peirce & Co's REGN Position: Q4 2020 in Review

Cookson Peirce & Co sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 987 shares — an estimated $553K sold.

Cookson Peirce & Co first reported a position in REGN in Q2 2015 and held it in 4 quarters. The position peaked at $553K in Q3 2020. 904 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

  • Cookson Peirce & Co reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Cookson Peirce & Co sold 987 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $553K.
  • Cookson Peirce & Co first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Cookson Peirce & Co's Regeneron Pharmaceuticals position peaked at $553K in Q3 2020.
  • 904 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Cookson Peirce & Co's 13F filing for Q4 2020, filed 10 Feb 2021.